Navigation Links
Choose New Jersey, Inc. to Tout New Jersey's Life Sciences Hub At World's Largest Biotechnology Event
Date:6/15/2012

PRINCETON, N.J., June 15, 2012 /PRNewswire/ -- Showcasing the Garden State's key business advantages and touting the state's flourishing life sciences industry, Choose New Jersey, Inc., along with Lt. Governor Kim Guadagno, the Business Action Center (BAC), BioNJ, the HealthCare Institute of New Jersey (HINJ) and other partners will be on site in Boston for the BIO International Convention on June 18-21.

The participation of New Jersey's delegation at the conference is preceded by this week's announcement that Governor Chris Christie has been named by the Biotechnology Industry Organization (BIO) as 2012 Governor of the Year in recognition of his leadership and commitment to advancing biotechnology and promoting public health.

"New Jersey offers unparalleled opportunities for pharmaceutical, biotechnology and medical device businesses. Raising awareness of these assets – like our strategic location and access to one of the best-educated and highly-skilled workforces in the country – is instrumental in our efforts to attract and retain companies in the state," said Lt. Governor Guadagno. "The considerable concentration of life science businesses in New Jersey and recent investments from major corporations are a testament to what the region has to offer, and we are eager to share our state's competitive advantages with this international audience."

Choose New Jersey, a nonprofit corporation created to promote New Jersey as a place in which to invest and do business, and BioNJ are organizing the state's largest presence at this show in recent history. The delegation will meet with targeted company prospects and media at the conference, which is the largest biotechnology event in the world and last year drew more than 15,000 industry leaders from 48 states and 65 countries.

"New Jersey is home to 17 out of the 20 largest pharmaceutical companies, with the highest concentration of scientists and engineers per capita in the nation," said Tracye McDaniel, president and CEO of Choose New Jersey. "We're serious about sharing the state's assets with this target group of professionals in order to attract new business and jobs."

Choose New Jersey is collaborating with the NJ Business Action Center, New Jersey universities and the state's leading life sciences organizations, BioNJ and HINJ, on the conference's New Jersey pavilion to showcase the state as a global life sciences hub. Participating universities include New Jersey Institute of Technology (NJIT), Princeton University, Rutgers University, and the University of Medicine and Dentistry of New Jersey (UMDNJ). Additional organizations representing NJ will be InnovationNJ and New Jersey Life Sciences Vendors Alliance.

Additionally, Lt. Governor Guadagno and Choose New Jersey will host prospect companies for a special event on June 19. Sponsored by HINJ, the evening will provide networking opportunities for some of the world's top life science executives and will feature music by the New Jersey Symphony Orchestra Chamber Players.

The first major launch of the state's new branding campaign, guided by a fresh slogan, "Highly educated, perfectly located," will also be unveiled at BIO through a newly designed pavilion and collateral material. Key messages about New Jersey's robust life sciences sector and resources available to companies will be shared with business leaders through highly targeted recruitment meetings and with trade media though face-to-face interviews.

About Choose New Jersey, Inc.
Choose New Jersey, Inc., a member of the Partnership for Action – including the NJ Business Action Center and the NJ Economic Development Authority – is responsible for executing New Jersey's economic development strategy. Choose New Jersey, Inc. is an independently funded and operated 501(c)(3) nonprofit corporation created to promote New Jersey as a place to invest and do business. For more information, visit www.choosenj.com.

Contact: Melissa Hensley, 609-297-2192
mhensley@choosenj.com


'/>"/>
SOURCE Choose New Jersey, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Garage Start-ups Now Possible in Life Sciences Industry
2. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
3. DiaTech Life Sciences Announces Medical Advisory Board
4. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
5. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
6. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
7. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
8. At-the-Market Offerings (ATM) of Life Sciences Companies Perform Well in Weak Follow-on Financing Environment of Third Quarter
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
11. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
Breaking Biology Technology:
(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
Breaking Biology News(10 mins):